Sung-Bae Cho
Chief Executive Officer bei CHOA PHARMACEUTICAL CO., LTD.
Vermögen: 1 Mio $ am 31.03.2024
Profil
Sung-Bae Cho is currently the President, Co-Chief Executive Officer & Director at ChoA Pharmaceutical Co., Ltd.
He previously worked as the Vice President at Medipharm.
Mr. Cho completed his undergraduate degree at Hanyang University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2023 | 750 000 ( 2,42% ) | 1 Mio $ | 31.03.2024 |
Aktive Positionen von Sung-Bae Cho
| Unternehmen | Position | Beginn |
|---|---|---|
| CHOA PHARMACEUTICAL CO., LTD. | Chief Executive Officer | 17.10.2014 |
Ehemalige bekannte Positionen von Sung-Bae Cho
| Unternehmen | Position | Ende |
|---|---|---|
Medipharm
 Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Corporate Officer/Principal | - |
Ausbildung von Sung-Bae Cho
| Hanyang University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CHOA PHARMACEUTICAL CO., LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Medipharm
Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Distribution Services |
